Table 1.
Patients’ sociodemographic and lifestyle characteristics presented in n (%).
Table 2.
Prevalence of comorbid conditions in Charlson comorbidity index presented in n (%).
Fig 1.
MUST steps for malnutrition screening.
(A) BMI. (B) Weight loss percentage. (C) Acute disease effect. (D) Malnutrition risk.
Table 3.
Patient’s biochemical levels presented in n (%).
Table 4.
Cancer-related characteristics presented in n (%).
Table 5.
Chemotherapy side effect frequency, severity, and daily activity effect presented in n (%) and mean (SD).
Table 6.
Cancer-induced taste alteration scale score presented in n (%) and mean (SD).
Table 7.
Coping and self-management strategies to deal with taste alterations presented in n (%).
Fig 2.
Prevalence of taste alteration according to CiTAS subscale.
(A) Basic taste reduction subscale. (B) Taste disorder (discomfort) subscale. (C) Phantogeusia and parageusia subscale. (D) General taste alterations subscale.
Table 8.
Changes in CiTAS according to nutritional status factors measured by malnutrition universal screening tool MUST.
Table 9.
Effect of sociodemographic factors and lifestyle on changes in CiTAS.
Table 10.
Effect of cancer-related data on taste alterations.
Table 11.
Changes in Ci-TAS according to chemotherapeutic side effects.
Table 12.
Effect of comorbidities on taste alterations.